EGFR and familial pancreatic carcinoma: EGFR inhibitors are employed in the treatment of various prevalent malignancies, such as breast, colon, lung, and pancreatic cancer.353,354 However, patients with advanced PDAC did not benefit from the addition of anti-EGFR antibodies to gemcitabine-backbone therapy.355